Evidence map›Paper›PMID 30023370›Full record

ArticleAnnals of translational medicine2018

Increasing clinical resistance rate of

Huimin Qian, Guoye Liu, Yin Chen, Ping Ma, Xiaoxiao Kong, Lu Zhou, Jie Hong, Changjun Bao, Bing Gu

Open access · hybridAbstract read
In one paragraph

Article in Annals of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Emerging microbes & infections · 2021
    Article
  6. Article
  7. Clonal dissemination of KPC-2-producingAnnals of translational medicine · 2019
    Article
  8. Existence of virulence genes in clinicalAnnals of translational medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Huimin Qian *Department of Acute Infectious Disease Prevention and Control, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210029, China.
Guoye Liu *Medical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Yin ChenMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Ping MaMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Xiaoxiao KongDepartment of Acute Infectious Disease Prevention and Control, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210029, China.
Lu ZhouDepartment of Acute Infectious Disease Prevention and Control, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210029, China.
Jie HongDepartment of Acute Infectious Disease Prevention and Control, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210029, China.
Changjun BaoDepartment of Acute Infectious Disease Prevention and Control, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210029, China.
Bing GuMedical Technology School, Xuzhou Medical University, Xuzhou 221004, China.
Jiangsu Provincial Center for Disease Control and Prevention · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study is to evaluate the prevalence of

methodsWe investigated the drug resistance in 95 isolates of

resultsOver a 4-year period, the resistance rate of

conclusionsThe antimicrobial resistance rate of

Indexed as

extended-spectrum beta-lactamases (ESBLs)resistanceShigella sonnei (S. sonnei)

Identifiers

PMID30023370
PMCPMC6035990
OpenAlexW2806646437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.